DS
FLNA

David Shaw’s Filana Therapeutics FLNA Stock Holding History

David Shaw’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,000
Closed -$295K – 4812
2022
Q4 		$295K Hold
10,000
– – ﹤0.01% 4094
2022
Q3 		$418K Hold
10,000
– – ﹤0.01% 4137
2022
Q2 		$281K Hold
10,000
– – ﹤0.01% 4391
2022
Q1 		$371K Hold
10,000
– – ﹤0.01% 4541
2021
Q4 		$437K Hold
10,000
– – ﹤0.01% 4474
2021
Q3 		$621K Hold
10,000
– – ﹤0.01% 3951
2021
Q2 		$854K Buy
+10,000
New +$536K ﹤0.01% 3673

Other funds holding FLNA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

David Shaw's FLNA Position: Q2 2026 in Review

David Shaw reduced its Filana Therapeutics (FLNA) stake by 13% in Q2 2026, selling an estimated $106K and leaving 485,025 shares worth $577K. The position accounts for ﹤0.01% of the portfolio, ranked #4111.

David Shaw first reported a position in FLNA in Q2 2013 and has held it in 30 quarters since. The position peaked at $5.13M in Q2 2021. 85 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • David Shaw held 485,025 shares of Filana Therapeutics worth $577K as of Q2 2026.
  • David Shaw sold 74,180 Filana Therapeutics shares in Q2 2026, an estimated $106K.
  • Filana Therapeutics made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #4111 holding.
  • David Shaw first reported a position in Filana Therapeutics in Q2 2013 and has held it in 30 quarters since.
  • David Shaw's Filana Therapeutics position peaked at $5.13M in Q2 2021.
  • 85 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.